Biomedical, Clinical & Life Sciences

T. Newton (College of Nursing)
S. Patel (College of Medicine ​​​ - ​​​​Tucson Campus)

UArizona may submit a total of three nominations:

• one nomination from the College of Nursing
• one nomination from the College of Medicine ​​​ - ​​​​Tucson Campus
• one nomination from the College of Medicine -  Phoenix Campus

Application portal will open in April 01, 2023

The Macy Faculty Scholars Program, now in its second decade, aims to identify and nurture promising early career educators in medicine and nursing. The program will help develop the next generation of national leaders in medical and nursing education by identifying outstanding educators, physicians, nurses, and role models—individuals who represent the breadth of diversity seen in learners, patient populations, and health care settings around the country. By providing the Scholars with resources—especially protected time, mentorship, and a professional network of colleagues—the program aims to accelerate Scholars’ careers, to turn their teaching practice into scholarship, and to help them become impactful leaders locally, nationally, and beyond.

Eligibility: 

1. Be a faculty member in a United States accredited nursing
   school, allopathic medical
   school, or osteopathic medical school. Candidates should have approximately three to eight years of full-time faculty experience at the time of application.

2. Be nominated by the dean of the nursing or medical school. There can be only one nominee per nursing or medical school.

3. Have a faculty mentor who will advise the candidate on the candidate’s educational project and career development.

4. Be a citizen or permanent resident of the United States or its territories.

This is a career development award. The Foundation is interested in candidates for whom the program will have the maximum impact at this point in their career and who also have the greatest possibility for future impact at their home institutions and beyond. Macy Faculty Scholars will participate in the Macy Faculty Scholars Annual Meeting and will be part of the family of Macy Faculty Scholars for the remainder of their careers.

In order to develop the careers of educators who are future leaders, the Macy Faculty Scholars Program will provide salary support for each Scholar up to $100,000 per year, which will protect 50% of the Scholar’s time over two years. The Scholar will devote this time to a mentored educational scholarly project and other appropriate career development activities.

No applicants // Limit: 1 // Tickets Available: 1 

UArizona may only apply for one grant in a grants cycle and only under one Tier.

The Quality of Life Grants Program impacts and empowers people living with paralysis, their families, and caregivers by providing grants to nonprofit organizations whose projects and initiatives foster inclusion, involvement, and community engagement while promoting health and wellness for those affected by paralysis. The impact can be demonstrated through the numbers of people served and other quantitative measures along with stories and examples of quality of life improvements.

Underserved Populations
Special consideration will be given to proposed projects that serve current military and/or veterans and their families, as well as those projects that target individuals with paralysis in underserved groups of the population, including (but not limited to): persons at risk of incarceration, current or released prisoners; ethnic minorities; homeless; indigenous or tribal communities; LGBTQ; limited English proficiency; rural residents; migrant workers; low-income and/or poverty populations; older adults/elderly; and newly injured people with paralysis and their caregivers.

No applicants // Limit: 1 // Tickets Available: 1 

The intent of the HHOW pediatric cancer research grants is to provide funding for principal investigators (herein referred to as “PI”), whose research projects are likely to have a significant impact on improving the understanding of the biology of childhood cancer and/or developing novel diagnostic, prognostic, and therapeutic approaches for pediatric malignancies. The grants are awarded to the institution for the benefit of the research of the approved projects. Projects eligible to be funded by this program will be those that pursue innovative research that is translational in nature, that is, has the potential to impact childhood cancer diagnosis and treatment. Proposals requesting support for clinical trials are not eligible for consideration.

Funding for the Grants is awarded to the applying institution (herein referred to as the applicant) for the purpose of supporting the PI and the research specified in the proposal. Submitting PIs must include a letter of support from the division chief of pediatric oncology at the applicant institution, and concurrence of the development office. With the submission of the Grant application(s), the PI(s) confirm(s) that each is authorized by the officers of the institution to submit the application and the institution agrees to abide by all terms and conditions of the grant.

The funds of awarded grants may not be transferred to a different institution under any circumstance, should the designated PI leave the institution for any reason.However, the institution may nominate a new qualified candidate to serve as the PI, subject to the new candidate meeting all guidelines and with no substantive changes to the approved project.

2023 HYUNDAI YOUNG INVESTIGATOR GRANT
The Hyundai Young Investigator’s Grant is a $200,000 grant, which will be provided as $100,000 per year grant for years 1 and 2.
Eligible Criteria for Young Investigator:

1. PI must be an MD or MD/PhD who is currently in his/her 3rd or 4th year of an accredited pediatric hematology-oncology fellowship training program and involved in pediatric cancer research; or
2. Must be a pediatric oncologist/MD, or MD/PhD in his/her initial academic appointment, within 6 years from completion of fellowship training, and involved in pediatric cancer research.
3. A PhD is not eligible to be a PI, for the purposes of the award, but may participate as a member of a research team.

Research proposals will be evaluated based on:

1. Relevance to pediatric cancer
2. Quality of science
3. Innovation
4. Potential for success
5. Potential impact on the field
6. Quality of applicant
7. Quality of institutional environment
8. Demonstrated need for funding

• Only ONE proposal in each category (i.e. one Young Investigator and one Scholar Hope may be submitted from any individual Applicant), for a total of TWO per institution.
• A PI may apply in either category, but not both. An applying PI may not have two HHOW grants at the same time. If the PI is a current HHOW grant awardee, they may not apply for a second HHOW grant award until the second year of their current award.
• Grant funds may be used to support bench or translational research and must have a direct relevance to pediatric cancer. 
• Less than 10% of funds can be used for indirect costs and no funds can be used for fringe benefits through the Scholar Hope or Young Investigator Grants.
• Applicants may use funds in conjunction with another award on the same topic. However, the difference has to be clearly identified in the budget.
• If Applicant has submitted multiple applications to other foundations or granting agencies, for funding the same project  concurrently, HHOW must be notified in the written application (Section VII below)
• The PI for either the Young Investigator or Hope Scholar award may not have more than 1 RO1 or RO1-equivalent at the time of application. K awards or equivalent are permitted for Young Investigator and Scholar PIs.

E. Katsanis ( College of Medicine - Pediatric Hematology / Oncology)

UA may submit one proposal. 

The intent of the HHOW pediatric cancer research grants is to provide funding for principal investigators (herein referred to as “PI”), whose research projects are likely to have a significant impact on improving the understanding of the biology of childhood cancer and/or developing novel diagnostic, prognostic, and therapeutic approaches for pediatric malignancies. The grants are awarded to the institution for the benefit of the research of the approved projects. Projects eligible to be funded by this program will be those that pursue innovative research that is translational in nature, that is, has the potential to impact childhood cancer diagnosis and treatment. Proposals requesting support for clinical trials are not eligible for consideration.

Funding for the Grants is awarded to the applying institution (herein referred to as the applicant) for the purpose of supporting the PI and the research specified in the proposal. Submitting PIs must include a letter of support from the division chief of pediatric oncology at the applicant institution, and concurrence of the development office. With the submission of the Grant application(s), the PI(s) confirm(s) that each is authorized by the officers of the institution to submit the application and the institution agrees to abide by all terms and conditions of the grant.

The funds of awarded grants may not be transferred to a different institution under any circumstance, should the designated PI leave the institution for any reason. However, the institution may nominate a new qualified candidate to serve as the PI, subject to the new candidate meeting all guidelines and with no substantive changes to the approved project.
 

2023 SCHOLAR HOPE GRANT

The Scholar Hope Grant is a $300,000 award (paid $150,000 per year), which may be used for up to two years. Approved funding may be used only for the purposes expressly set forth in the applicant’s proposal and specifically performed under the auspices of the PI identified in the proposal.

Applicant eligibility for Scholar Hope Grant:

1. PI must be an MD or MD/PhD whose research is focused on pediatric oncology.
2. A PhD is not eligible to be a PI, for the purposes of the award, but may participate as a member of a research team.
3. PIs must have completed their fellowship sub-specialty training at the time of the award.
4. Applicant may have no more than 1 R01 or R01-equivalent grant, at the time of application.
5. Applicants must be based in and research is focused on projects within the U.S. market.
6. Clinical research studies or medical trials are not eligible for consideration.
7. Applicant may not have concurrent HHOW funding, but may apply during the second year of funding for a second HHOW grant (i.e. consecutive funding).

Research proposals will be evaluated based on:

1. Relevance to pediatric cancer
2. Quality of science
3. Innovation
4. Potential for success
5. Potential impact on the field
6. Quality of applicant
7. Quality of institutional environment
8. Demonstrated need for funding

• Only ONE proposal in each category (i.e. one Young Investigator and one Scholar Hope may be submitted from any individual Applicant), for a total of TWO per institution.
• A PI may apply in either category, but not both. An applying PI may not have two HHOW grants at the same time. If the PI is a current HHOW grant awardee, they may not apply for a second HHOW grant award until the second year of their current award.
• Grant funds may be used to support bench or translational research and must have a direct relevance to pediatric cancer. 
• Less than 10% of funds can be used for indirect costs and no funds can be used for fringe benefits through the Scholar Hope or Young Investigator Grants.
• Applicants may use funds in conjunction with another award on the same topic. However, the difference has to be clearly identified in the budget.
• If Applicant has submitted multiple applications to other foundations or granting agencies, for funding the same project  concurrently, HHOW must be notified in the written application (Section VII below)
• The PI for either the Young Investigator or Hope Scholar award may not have more than 1 RO1 or RO1-equivalent at the time of application. K awards or equivalent are permitted for Young Investigator and Scholar PIs.

Apply to the UA internal competition.
UA may submit one proposal.

The mission of the Foundation is to support early stage investigators engaged in basic biomedical research that has the potential to significantly advance the understanding, diagnosis or treatment of disease.

The funds are designed to provide to tenure track faculty members in their first to fourth year, at American Institutions, who hold M.D. and/or Ph.D. degrees, start-up support to move the project forward to the point where R01 or other independent funding can be obtained.  Applicants with current R01 funding should not apply.

Grant provides $60,000 annually for a period of up to three years.  Grants are not renewable.  Institutions may submit one proposal per session.  Interested candidates should work through their sponsored projects office.

Proposals must contain an adequately detailed description of the project to be clearly understandable by the scientific members of the Trustees.  They need not be in the detail requested by the NIH for R01 grants and should not exceed five pages in length.  Additional material can be submitted, but the five-page application should contain the essential information.  References should also be included to support the proposal.  Note that the five page limit is only for the project description.  

In addition to the institution providing recognition of an internal selection process resulting in no more than one candidate, (this requires just a sentence that may be included in the letters), the proposal must be accompanied by letters of approval by the Dean of the medical school and/or another senior faculty member or members who can represent the support of the institution and who are acquainted with the qualifications of the applicant and the potential impact of his/her work.

Institutionally Coordinated.
Please contact RDS for more information. 

The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), invites grant applications for Education and Research Centers (ERCs) that are focused on occupational safety and health training. NIOSH is mandated to provide an adequate supply of qualified personnel to carry out the purposes of the Occupational Safety and Health Act, and the ERCs are one of the primary means for meeting this mandate.

ERCs are academic institutions that provide high-quality interdisciplinary graduate and post-graduate training, research training, continuing education, and outreach in the core occupational safety and health disciplines of industrial hygiene, occupational health nursing, occupational medicine, and occupational safety, as well as allied disciplines.

Research and research training are integral components of ERCs, with ERC faculty and NIOSH trainees conducting research on issues related to the NIOSH National Occupational Research Agenda (NORA) and emerging issues to advance the field of occupational safety and health. 

NIOSH ERCs have regional presence to further diversify the occupational safety and health profession through their core values, mission statements, and outputs.

ERCs serve as resources for our nation's workforce through continuing education, outreach and strong collaboration with professional associations, worker advocacy groups, businesses, industries, and public health agencies. ERCs work with other institutions and organizations, including Minority Serving Institutions and other NIOSH supported training programs to have a positive impact on worker health, safety, and well-being. 

No applicants // Limit: 1 // Tickets Available: 1 

The NOFO contains 3 components: A, B, and C. UA may apply for only 1 component.

This NOFO seeks to decrease risk for type 2 diabetes among adults with prediabetes and improve self-care practices, quality of care, and early detection of complications among people with diabetes. Additionally, this NOFO will support implementation of evidence-based, family-centered childhood obesity interventions as a type 2 diabetes risk reduction strategy. The NOFO includes 3 components. Applicants may apply for only 1. Components A and B focus on a menu of strategies to decrease risk for type 2 diabetes among adults at high risk; improve selfcare practices, quality of care, and early detection of complications among priority populations with diabetes; and support implementation of family-centered childhood obesity interventions to reduce risk for type 2 diabetes. Component A will fund 51 organizations physically located in each of the 50 states and the District of Columbia to achieve state/district-wide reach. Component B will fund up to 22 organizations to work in US counties identified as “high need” based on diabetes burden and social vulnerability; applicants’ work must reach a population > 350,000 across one or more of these counties, in partnership with local organizations. Component C will fund 3-4 multisectoral partnership networks to simultaneously and collaboratively address 4 aspects of work proven necessary to scale and sustain the National Diabetes Prevention Program to better engage, enroll, and retain large numbers of participants. 

M.K. Johnson 
The submission for this funding program is coordinated with UA Foundation. 
 

The New Innovator in Food & Agriculture Research Award provides early-career scientists the investment needed to propel them into successful research careers.

Young faculty in the sciences often struggle to secure grant funding. We established the New Innovator Awards to launch the careers of promising scientists whose research addresses significant food and agriculture challenges. These awards allow the grantees to focus exclusively on research without the pressure of securing additional funding.

We grant New Innovator Awards to outstanding early career investigators who have been in the tenure-track position no longer than three years. The Award goes to individuals with the creative ideas, skills, knowledge and resources necessary to carry out the proposed research program.

We give preference to individuals who are within eight years of receiving a Ph.D. or equivalent degree. Eligible candidates must also conduct research that aligns with our Challenge Areas.

Individuals with significant research experience prior to obtaining their faculty position are not eligible for this award.

Each applicant can receive from FFAR up to $150,000 per year for a maximum of three years totaling $450,000 investment.

To further support the grantees, and allow them to fully focus on their research, matching funds are not required for this program.

No applicants // Limit: 1 // Tickets Available: 1 

Through this solicitation, NSF seeks to foster a network of S-STEM stakeholders and further develop the infrastructure needed to generate and disseminate new knowledge, successful practices and effective design principles arising from NSF S-STEM projects nationwide. The ultimate vision of the legislation governing the S-STEM parent program[1] (and of the current S-STEM-Net solicitation) is that all Americans, regardless of economic status, should be able to contribute to the American innovation economy if they so desire.

To support collaboration within the S-STEM network, NSF will fund several S-STEM Research Hubs (S-STEM-Hub). The S-STEM Network (S-STEM-Net) will collaborate to create synergies and sustain a robust national ecosystem consisting of multi-sector partners supporting domestic low-income STEM students in achieving their career goals, while also ensuring access, inclusion, and adaptability to changing learning needs. The Hubs will investigate evolving barriers to the success of this student population. It will also disseminate the context and circumstances by which interventions and practices that support graduation of domestic low-income students (both undergraduate and graduate) pursuing careers in STEM are successful.

The target audience for this dissemination effort is the community of higher education institutions, faculty, scholars, researchers and evaluators, local and regional organizations, industry, and other nonprofit, federal, state, and local agencies concerned with the success of domestic low-income STEM students in the United States.

No applicants // Limit: 1 // Tickets Available: 1 

This Funding Opportunity Announcement (FOA) invites applications for Silvio O. Conte Digestive Diseases Research Core Centers (DDRCCs). The DDRCCs are part of an integrated program of digestive and liver diseases research support provided by the NIDDK. The purpose of this Centers program is to bring together basic and clinical investigators as a means to enhance communication, collaboration, and effectiveness of ongoing research related to digestive and/or liver diseases within the NIDDK's mission. DDRCCs are based on the core concept, whereby shared resources aimed at fostering productivity, synergy, and new research ideas among the funded investigators are supported in a cost-effective manner. Each proposed DDRCC must be organized around a central theme that reflects the focus of the digestive or liver diseases research of the Center members. The central theme must be within the primary mission of the NIDDK, and not thematic areas for which other NIH Institutes or Centers are considered the primary source of NIH funding.